Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: A study from the National Center for Precision Medicine (PRISM).
In this interview, Cerba Research describes how its teams were able to detect resident memory T cells in solid tumors thanks to multiplex immunofluorescence. Could you provide an overview of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback